Navigation Links
Co-Promotion of a New Medical Device for Female Infertility Announced
Date:1/18/2011

SPARTANBURG, S.C., Jan. 18, 2011 /PRNewswire/ -- Norgenix Pharmaceuticals, LLC (www.norgenixpharma.com), a wholly owned subsidiary of Spartanburg-based J M Smith Corporation, and Fertility Focus Limited (www.fertility-focus.com) today announced a partnership for the co-promotion of the Fertiloscope, a CE marked and 510(k) approved surgical instrument for the early diagnosis and immediate corrective surgery of physical causes of female infertility. Norgenix has exclusive rights to market and distribute the Fertiloscope in the United States, as well as US territories and military bases. The product will benefit from the strategic support of Glenveigh Medical (www.glenveigh.com) as well, with whom Norgenix has an existing alliance in the U.S. to promote medical devices developed by Glenveigh.

Norgenix and Fertility Focus also announced a strategic alliance and revealed its first medical device co-promotion, the Fertiloscope. Norgenix is a North American specialty pharmaceutical, medical device and biotechnology company that engages in the development, commercialization, and sales of products in the women's health arena. Norgenix is licensed to sell, market, and distribute prescription drug products and medical devices in all 50 U.S. states. Fertility Focus is a United Kingdom based company that develops devices aimed at the infertility market.

Developed by the eminent French surgeon Dr. Antoine Watrelot, the Fertiloscope, is a novel laparoscope for minimally invasive trans-vaginal use in a procedure that is known as Fertiloscopy. The Fertiloscopeis the only method of primary screening that provides gold standard accuracy in a day-case or office setting. This relatively new surgical technique is used for the early diagnosis and immediate treatment of a number of disorders of the female reproductive organs.

Norgenix is dedicated to in-licensing product opportunities and building strategic alliances with companies interested in maximizing the value of products that fulfill unmet medical needs in the U.S. marketplace. As a strategic partner, Norgenix and the related J M Smith partner companies will provide strategic direction and capitalization to build success.MEDIA CONTACT:  Sims Hammond 864.580.2350 Sims@LaunchSomething.com
'/>"/>

SOURCE Norgenix Pharmaceuticals, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 4th Edition
2. Nautilus Neurosciences and Mission Pharmacal Announce Exclusive Co-Promotion Agreement for CAMBIA™ (diclofenac potassium for oral solution) for the Acute Treatment of Migraine to the Womens Health Market
3. Warner Chilcott Agrees to Terminate Existing Co-Promotion Agreement and Acquire U.S. Rights to Enablex® Overactive Bladder Treatment for $400 Million in Cash
4. Lilly, Kowa and Kowa Pharmaceuticals America Announce Co-Promotion and Licensing Agreement
5. Timm Medical Technologies and Ferring Pharmaceuticals Enter Exclusive Co-Promotion Agreement for Prosed(R) DS
6. Daiichi Sankyo and Forest Laboratories Finalize Contract for Co-Promotion of AZOR(TM)
7. Octapharma Targets Primary Immune Deficiency Research With Grant for The Mount Sinai Medical Center
8. Rochester Medical Announces First Quarter 2011 Earnings Conference Call Tuesday, January 25, 2011
9. Vasomedical Reports Financial Results for the Quarter Ended November 30, 2010
10. Mindray Medical to Exhibit at Arab Health 2011 in Dubai from January 24-27
11. Emerging Markets Are Gaining Ground in Medical Technology Innovation; U.S. Maintains Lead, Finds PwCs Medical Technology Innovation Scorecard
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2019)... ... December 06, 2019 , ... The Multiple System Atrophy ... its bold new initiative to kickstart MSA research collaborations. Multiple system atrophy ... Infused by $3 million in new bequests earmarked for research and combined with ...
(Date:12/5/2019)... ... December 05, 2019 , ... LeadingBiotech ,?an ... today announces key issues to be discussed at its East/West CEO ... in San Francisco. , Kicking off the week of the ...
(Date:12/4/2019)... (PRWEB) , ... December 04, ... ... leader in delivering solutions designed for improved financial, operational and clinical health ... earned the Fellow designation from the American College of Healthcare Executives (ACHE). ...
Breaking Medicine Technology:
(Date:12/6/2019)... ... ... Sponsors Toys for Tots to Give Free Toys to Children in Need , Dr. Alexis ... Holidays , Lasair Aesthetic Health is spreading holiday cheer again this year by sponsoring the ... toys worth more than 25-dollars, will get FIVE units of Botox (a $60 value) for ...
(Date:12/6/2019)... ... December 06, 2019 , ... ... professionals in Baltimore, Maryland at the AES Annual Meeting. The symposium, “Fundamentals of ... 1. Understand methods of quantitative sEMG analysis during ictal events;, 2. Review specific ...
(Date:12/6/2019)... CYPRESS, Calif. (PRWEB) , ... December 06, 2019 , ... ... Health Sciences program, recently published research on the health benefits of coconut oil ... “Coconut Oil Intake and Its Effects on the Cardiometabolic Profile: A Structured Literature Review,” ...
(Date:12/5/2019)... ... December 05, 2019 , ... Abide, the #1 Christian ... million times this year using Bible-based bedtime stories. Listeners have recovered from bad dreams ... to the Center for Disease Control, one third of Americans suffer from poor sleep, ...
(Date:12/5/2019)... ... December 05, 2019 , ... ... has announced the Top 54 RHIT Degree Programs for 2020. The comprehensive research ... the nation. Each program is evaluated based on curriculum quality, graduation rate, reputation, ...
Breaking Medicine News(10 mins):